Southeast Asia Gemfibrozil Market Poised for Steady Growth Tackling Cardiovascular Disease Through 2030
Southeast Asia Gemfibrozil Market, a critical segment within the pharmaceutical active ingredients sector, is poised for steady growth through 2030. As a lipid-regulating drug widely used to treat hypertriglyceridemia, gemfibrozil maintains consistent demand across Thailand, Indonesia, Vietnam, and other ASEAN nations grappling with rising cardiovascular disease prevalence. While precise...
0 Comments 0 Shares 36 Views 0 Reviews